Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2020 (Donepezil) in Severe Alzheimer's Disease
NCT00165659Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2002
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Nov 2002; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00165659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165659.